Atrial Fibrillation Market Overview ,Analysis And Future Scope For 2025| Grand View Research, Inc
“Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain.�
The global atrial fibrillation market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand. Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry
Follow Us:
North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth. Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth. Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years. Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period. Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., SanofiAventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency. Grand View Research has segmented the global atrial fibrillation market on the basis of fields of procedures and region: Atrial Fibrillation Procedures Outlook Pharmacological Products
o
Anti-arrhythmic Drugs
o
Anti-coagulant Drugs
Non-Pharmacological Treatment o
Catheter Ablation Procedures Radiofrequency HIFU Cryoablation Microwave Laser
o
Maze Surgery
o
Electric Cardioversion
Atrial Fibrillation Regional Outlook North America
Follow Us:
Europe
Asia Pacific
RoW
Browse Related Category Reports @ www.grandviewresearch.com/industry/pharmaceuticals Table of Content of Atrial Fibrillation Market Chapter 1. Executive Summary 1.1. Atrial fibrillation - Industry Summary & Critical Success Factors (CSFs) Chapter 2. Atrial fibrillation Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Atrial fibrillation Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Atrial fibrillation -Company Market Share Analysis, 2013 2.7. Atrial fibrillation Market PESTEL Analysis, 2013 Chapter 3. Atrial fibrillation Procedures Outlook 3.1. Pharmacological Drugs 3.1.1. Global Pharmacological Drugs for Atrial Fibrillation demand, 2012 - 2020 (USD Million) 3.1.1.1. Global Pharmacological Drugs Market demand, 2012 - 2020 (USD Million) 3.1.1.2. Anti-arrhythmic Drugs Market demand, 2012 - 2020 (USD Million) 3.1.1.3. Anti-coagulant Drugs Market demand, 2012 - 2020 (USD Million) 3.2. Non-Pharmacological Procedures 3.2.1. Global Catheter Ablation Procedures demand, 2012 - 2020 (USD Million) 3.2.1.1. Radiofrequency Catheter Ablation demand, 2012 - 2020 (USD Million) 3.2.1.2. HIFU Catheter Ablation demand, 2012 - 2020 (USD Million) 3.2.1.3. Catheter Cryoablation demand, 2012 - 2020 (USD Million) 3.2.1.4. Microwave Catheter Ablation demand, 2012 - 2020 (USD Million) 3.2.1.5. Laser Catheter Ablation demand, 2012 - 2020 (USD Million) 3.2.2. Global Maze Surgery demand, 2012 - 2020 (USD Million) 3.2.3. Global Electric Cardioversion demand, 2012 - 2020 (USD Million)
Follow Us:
Chapter 4. Atrial fibrillation Regional Outlook 4.1. North America 4.1.1. North America atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million) 4.2. Europe 4.2.1. Europe atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million) 4.3. Asia Pacific 4.3.1. Asia Pacific atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million) 4.4. RoW 4.4.1. RoW atrial fibrillation market revenue by procedure, 2012 - 2020 (USD Million) Chapter 5 Company Profiles 5.1 AtriCure Inc. 5.1.1 Company overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 Biosense Webster Inc. 5.2.1 Company overview 5.2.2 Product Benchmarking 5.2.3 Strategic Initiatives 5.3 Boehringer Ingelheim GmbH 5.3.1 Company overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 Boston Scientific Corporation 5.4.1 Company overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 Bristol- Myers Squibb Corporation 5.5.1 Company overview 5.5.2 Financial Performance
Follow Us:
5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 Cardio Focus Inc. 5.6.1 Company overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Endoscopic Technologies Inc. 5.7.1 Company overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 Sanofi Aventis 5.8.1 Company overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 St. Jude Medical Inc. 5.9.1 Company overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 Johnsons & Johnson Ltd 5.10.1 Company overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources
Follow Us:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: